Übersicht
Veränderung der Aktienkurses
24h
Aktuell
Min
9.96
Max
12.06
Empfehlungen | Sell |
|---|---|
12-Monats-Prognose | -29.14% downside |
Ginkgo Bioworks Holdings Inc Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
6. Nov. 2026, 21:03 UTC
Ginkgo Bioworks reports results below consensus estimates, yet shares are sharply higher, marking a divergence from the recent trend of higher daily closes.
Lesen
5. Nov. 2026, 23:03 UTC
Ginkgo Bioworks reports Q3 net loss of $40.984 million, or $0.64 per share, with revenue down 5.7% to $27.711 million, reaffirming 2026 cash burn target.
Lesen
4. Nov. 2026, 21:03 UTC
Ginkgo Bioworks Holdings, Inc. is sharply higher, reaching a notable peak today, with a cumulative return since Tuesday fluctuating over 8%.
Lesen
3. Nov. 2026, 21:02 UTC
Ginkgo Bioworks Holdings, Inc. is trading sharply higher, gaining significantly since Monday's close after a period of weaker performance and recent session declines.
Lesen
2. Nov. 2026, 21:05 UTC
Ginkgo Bioworks Holdings, Inc. shares fell, breaking a streak of higher daily closes since Friday, amid contrasting upward momentum in prior sessions.
Lesen
30. Okt. 2026, 23:06 UTC
Ginkgo Bioworks Holdings, Inc. shares advanced in after-market hours following a cumulative return that peaked shortly after the market closed.
Lesen
29. Okt. 2026, 23:02 UTC
Ginkgo Bioworks is sharply lower in after-market trading, following a decline in the ARK Genomic Revolution ETF amid weakness from Illumina's earnings report.
Lesen
28. Okt. 2026, 23:41 UTC
Ginkgo Bioworks Holdings, Inc. is trading lower in after-market hours, following a significant decline in the broader market and reaching its lowest cumulative return of the day.
Lesen
27. Okt. 2026, 20:02 UTC
Ginkgo Bioworks Holdings, Inc. shares are sharply higher, continuing a trend of increased daily closes since Monday's close.
Lesen
23. Okt. 2026, 20:07 UTC
Ginkgo Bioworks Holdings Inc shares are advancing significantly, recovering from earlier session lows, though still below their 20-day moving average.
Lesen
22. Okt. 2026, 20:07 UTC
Ginkgo Bioworks Holdings Inc shares are declining, reflecting broader biotechnology sector volatility and the ARK Genomic Revolution ETF's significant drop due to key holdings.
Lesen
20. Okt. 2026, 20:08 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply, continuing a trend of lower daily closes amid broader market losses since Monday's close.
Lesen
19. Okt. 2026, 19:46 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply, reaching a notable low earlier in the session, and remain significantly below their 20-day moving average.
Lesen
16. Okt. 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are trading lower in after-market hours, reflecting broader market declines amid inflation concerns and rising borrowing costs.
Lesen
15. Okt. 2026, 20:08 UTC
Sharply higher after $200M offering, clinical updates; sympathy with Ginkgo.
Lesen
14. Okt. 2026, 23:21 UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, reflecting broader market declines driven by poor tech earnings and rising crude oil prices.
Lesen
13. Okt. 2026, 22:06 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading, having retraced from an earlier peak and reaching a low nearly 1.9% below Tuesday's close.
Lesen
12. Okt. 2026, 23:16 UTC
Ginkgo Bioworks Holdings Inc gained slightly in after-market trading, maintaining a position roughly flat since Monday's close.
Lesen
10. Okt. 2026, 00:01 UTC
Ginkgo Bioworks Holdings Inc is trading modestly higher in after-market hours, supported by a strong broader market backdrop and positioning above its 20-day moving average.
Lesen
9. Okt. 2026, 20:02 UTC
Ginkgo Bioworks joins the National Science Foundation’s X-Labs program, committing $1.5 billion in in-kind support for independent research teams.
Lesen
8. Okt. 2026, 23:42 UTC
Ginkgo Bioworks to provide in-kind access to its Boston lab for the National Science Foundation’s $1.5 billion X-Labs program supporting independent research teams.
Lesen
7. Okt. 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, marking its third consecutive session of declines following a significant dip earlier in the day.
Lesen
6. Okt. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply after an earlier session high, continuing a significant decline since Monday's close amid mixed social media sentiment.
Lesen
5. Okt. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc gains amid positive online commentary about its growth potential and connection to GPT-5, despite trading lower compared to earlier sessions.
Lesen
2. Okt. 2026, 20:07 UTC
Ginkgo Bioworks Holdings Inc shares fell sharply, continuing a decline from Thursday's close despite remaining above its 20-day moving average.
Lesen
1. Okt. 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc is trading modestly lower in after-market hours, retracing from a brief peak earlier, despite strong performance over the past month.
Lesen
30. Sept. 2026, 20:02 UTC
Ginkgo Bioworks is trading higher after securing a $17.5 million contract from ARPA-H and expanding its Nebula lab, now the world's largest autonomous lab.
Lesen
29. Sept. 2026, 23:11 UTC
Ginkgo Bioworks Holdings Inc. sees increased social media attention and gains in after-market trading, maintaining a strong upward trend above its 20-day moving average.
Lesen
28. Sept. 2026, 23:06 UTC
Ginkgo Bioworks Holdings Inc traded roughly flat during after-market hours, remaining well above its 20-day moving average amid broader market gains over the past month.
Lesen
25. Sept. 2026, 20:02 UTC
Ginkgo Bioworks Holdings Inc. shares are higher as CEO highlights maturing investments in autonomous lab robotics and advancements in AI driving business momentum.
Lesen
Peer-Vergleich
Kursveränderung
Ginkgo Bioworks Holdings Inc Prognose
Kursziel
By TipRanks
12-Monats-Prognose
Durchschnitt 8 USD -29.14%
Hoch 11 USD
Tief 5 USD
Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Ginkgo Bioworks Holdings Inc – Dist angeboten haben.
Rating-Konsens
By TipRanks
Sell
3 ratings
0
Buy
1
Halten
2
Sell
Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Ginkgo Bioworks Holdings Inc – Dist abgegeben haben.
Finanzen
$